Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

467
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
467

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Passive heart-rate monitoring during smartphone use in everyday life.

Nature·2026
Same author

Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma.

Histopathology·2026
Same author

Advancing conversational diagnostic AI with multimodal reasoning.

Nature medicine·2026
Same author

Microscale organization and separability of upper extremity representations in the human motor homunculus.

Research square·2026
Same author

Consumer Understanding of Skin Concerns With an AI-Powered Informational Tool.

JAMA dermatology·2026
Same author

Authors' Reply: Advancing Digital Pathology With Large Language Models.

Advances in anatomic pathology·2026
Same journal

Enhancement of sleep slow wave activity using transcranial electrical stimulation with temporal interference: an interim analysis of the STRENGTHEN study.

Communications medicine·2026
Same journal

Differentiating genetic and gene-environment interaction profiles of physical and mental health disorders.

Communications medicine·2026
Same journal

Paired longitudinal tear proteomics reveals persistent ocular surface dysregulation after teprotumumab therapy in thyroid eye disease.

Communications medicine·2026
Same journal

In vitro development of the Autonomous Colonoscope Robot System (ACRS) for fully automated colonoscope insertion.

Communications medicine·2026
Same journal

Dynamic contrast-enhanced ultrasound predicts microsphere biodistribution in real-time during transarterial radioembolization.

Communications medicine·2026
Same journal

Circulating monocyte gene expression profiles associated with cardiac remodeling and incident heart failure in the Multi-Ethnic Study of Atherosclerosis.

Communications medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 22, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

689

Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.

Ellery Wulczyn1, Kunal Nagpal1, Matthew Symonds1

  • 1Google Health, Palo Alto, CA USA.

Communications Medicine
|May 23, 2022
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) for prostate cancer Gleason grading shows promise in predicting cancer-specific mortality. This AI tool effectively risk-stratifies patients, potentially improving disease management.

Keywords:
Prognostic markersProstate cancer

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

297
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

391

Related Experiment Videos

Last Updated: Sep 22, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

689
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

297
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

391

Area of Science:

  • Urology
  • Pathology
  • Medical Artificial Intelligence

Background:

  • Prostate cancer Gleason grading is crucial for prognosis but lacks reproducibility among pathologists.
  • While AI tools match expert Gleason grading, their impact on patient prognostication is unclear.

Purpose of the Study:

  • To develop and evaluate an AI system for predicting prostate cancer-specific mortality using AI-based Gleason grading.
  • To assess the AI system's ability to risk-stratify patients compared to traditional methods.

Main Methods:

  • Developed an AI system for Gleason grading to predict prostate cancer-specific mortality.
  • Evaluated the AI system on a retrospective cohort of 2807 prostatectomy cases with 5-25 years of follow-up.

Main Results:

  • The AI system achieved a C-index of 0.84 for predicting prostate cancer-specific mortality.
  • Discretized AI risk scores (analogous to Grade Groups) yielded a C-index of 0.82.
  • AI grading showed improved prognostication compared to pathologist-derived Grade Groups from reports (C-indices 0.87/0.85 vs. 0.79).

Conclusions:

  • AI-based Gleason grading effectively stratifies patients by risk for prostate cancer-specific mortality.
  • The findings suggest AI grading warrants further investigation for enhancing prostate cancer management.